Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

This study is ongoing, but not recruiting participants.

Study NCT00070343 Information provided by National Cancer Institute (NCI)

First Received: October 3, 2003 Last Updated: April 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given